Hyman B Muss

Efficacy, toxicity, and quality of life in older women with early-stage breast cancer treated with letrozole or placebo after 5 years of tamoxifen: NCIC CTG intergroup trial MA.17.

Dongsheng Tu, Martine J Piccart, James N Ingle, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Endocrine Therapy for Hormone Receptor-Positive Metastatic Breast Cancer: American Society of Clinical Oncology Guideline.

Lesley Fallowfield, Mohammad Jahanzeb, Debra L Barton, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Improved outcomes from adding sequential Paclitaxel but not from escalating Doxorubicin dose in an adjuvant chemotherapy regimen for patients with node-positive primary breast cancer.

Richard L Schilsky, Larry Norton, James N Ingle, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Discrepancy between preference and actual adjuvant therapy for breast cancer.

Takamaru Ashikaga, T. Ashikaga, H. Muss, 2010, Clinical breast cancer.

ACCO: ASCO core curriculum outline.

J. V. Von Roenn, L. Deangelis, P. Harari, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Randomized trial of letrozole following tamoxifen as extended adjuvant therapy in receptor-positive breast cancer: updated findings from NCIC CTG MA.17.

Robert B Livingston, Dongsheng Tu, Jeffrey S Abrams, 2005, Journal of the National Cancer Institute.

Accuracy and outcomes of screening mammography in women with a personal history of early-stage breast cancer.

Karla Kerlikowske, Les Irwig, Diana L Miglioretti, 2011, JAMA.

American Society of Clinical Oncology 2006 update of the breast cancer follow-up and management guidelines in the adjuvant setting.

Thomas J. Smith, Thomas J Smith, Eva Grunfeld, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Randomized trial of dose-dense versus conventionally scheduled and sequential versus concurrent combination chemotherapy as postoperative adjuvant treatment of node-positive primary breast cancer: first report of Intergroup Trial C9741/Cancer and Leukemia Group B Trial 9741.

Barbara L. Smith, Robert Livingston, Richard L Schilsky, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.